{"protocolSection": {"identificationModule": {"nctId": "NCT01158573", "orgStudyIdInfo": {"id": "36879"}, "organization": {"fullName": "University of Michigan", "class": "OTHER"}, "briefTitle": "Role of Cysteinyl Leukotrienes in the Pathogenesis of Asthma in Obesity", "officialTitle": "Role of Cysteinyl Leukotrienes in the Pathogenesis of Asthma in Obesity"}, "statusModule": {"statusVerifiedDate": "2017-06", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2010-07"}, "primaryCompletionDateStruct": {"date": "2013-05", "type": "ACTUAL"}, "completionDateStruct": {"date": "2013-05", "type": "ACTUAL"}, "studyFirstSubmitDate": "2010-07-07", "studyFirstSubmitQcDate": "2010-07-07", "studyFirstPostDateStruct": {"date": "2010-07-08", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2015-12-14", "resultsFirstSubmitQcDate": "2017-06-14", "resultsFirstPostDateStruct": {"date": "2018-01-24", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2017-06-14", "lastUpdatePostDateStruct": {"date": "2018-01-24", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "PRINCIPAL_INVESTIGATOR", "investigatorFullName": "Michael Coffey", "investigatorTitle": "Associate Professor Internal Medicine, Pulmonary Division", "investigatorAffiliation": "University of Michigan"}, "leadSponsor": {"name": "University of Michigan", "class": "OTHER"}, "collaborators": [{"name": "Merck Sharp & Dohme LLC", "class": "INDUSTRY"}]}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "The purpose of this study is to examine whether there are higher levels of cysteinyl leukotrienes in obese subjects than in non-obese subjects. Cysteinyl leukotrienes are pro-inflammatory substances that cause asthma by narrowing the airways of the lung. The investigators want to see if subjects with increased fat stores and therefore increased leptin, which is a fat-related protein that regulates leukotrienes, have increased levels of leukotrienes in the blood, lung and urine. The investigators would also like to determine the relationship between cysteinyl leukotrienes and exhaled nitric oxide levels in asthmatics with and without obesity. Nitric oxide is anti-inflammatory and suppresses leukotriene synthesis.", "detailedDescription": "This is a cross-sectional observational study to characterize the association between obese asthmatics and the inflammatory mediators cysteinyl leukotrienes. Our hypothesis is that altered adipokine levels in obesity result in augmented cysteinyl leukotriene synthesis that play a significant role in the pathogenesis of asthma in these subjects."}, "conditionsModule": {"conditions": ["Asthma", "Obesity"], "keywords": ["Asthma", "Obesity"]}, "designModule": {"studyType": "OBSERVATIONAL", "designInfo": {"observationalModel": "CASE_CONTROL", "timePerspective": "CROSS_SECTIONAL"}, "bioSpec": {"retention": "SAMPLES_WITHOUT_DNA", "description": "Subjects will provide 30 cc of blood, a urine sample and we will collect 1-2 ml. of exhaled breath condensate for analysis."}, "enrollmentInfo": {"count": 117, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Healthy non-asthmatic obese adults", "description": "Healthy non-asthmatic obese adults"}, {"label": "Healthy non-asthmatic non-obese adults", "description": "Healthy non-asthmatic non-obese adults"}, {"label": "Asthmatic obese adults", "description": "Asthmatic obese adults"}, {"label": "Asthmatic non-obese adults", "description": "Asthmatic non-obese adults"}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Plasma Leptin", "description": "Measurement of plasma leptin in obese and non obese asthmatics and non-asthmatic subjects from a single blood draw.", "timeFrame": "Observational: one time point from a blood draw after more than 6 hours fasting"}, {"measure": "Exhaled Nitric Oxide (FeNO)", "description": "Exhaled breath nitic oxide ppb (averaged values from 2 exhalations per participant)", "timeFrame": "Observational: Two exhalations within 1 minute"}, {"measure": "Urine Cysteinyl Leukotriene Per Creatinine", "description": "Urine inflammatory mediators measured from a single urine sample", "timeFrame": "sample taken over 5 minutes or less"}, {"measure": "Ratio U Cys-LT/FeNO", "description": "Responsiveness to leukotriene modifier medication by measuring the urine cysteinyl leukotriene/exhaled nitric oxide ratio", "timeFrame": "sample taken over 5 minutes or less"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* 18-65 yr old adults with asthma, non-smoking for at least one year\n* Healthy non-smoking adults, aged 18-65 without asthma\n* Heavy subjects with BMI \\> 30 kg/m2\n* Subjects with normal weight (BMI between 20-25 kg/m2)\n* Subject not taking anti-leukotriene therapy (Singulair, Accolate, Zyflo)\n\nExclusion Criteria:\n\n* No chronic oral steroid use\n* No recent history of infection\n* No recent history of flare of lung disease", "healthyVolunteers": true, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "65 Years", "stdAges": ["ADULT", "OLDER_ADULT"], "studyPopulation": "UM Housing Residents/Student Dorms UM Human Research Recruiting Registry (e.g., ENGAGE - http://www.med.umich.edu/engage/) Department or unit-specific research recruiting registry (provide UM IRB project number below) Other UM subject pools (describe below) Patients or their medical records from the UM Health System or any other UM health care provider (e.g., School of Dentistry, University Health Service, University Center for Language and Literacy)", "samplingMethod": "NON_PROBABILITY_SAMPLE"}, "contactsLocationsModule": {"overallOfficials": [{"name": "Michael Coffey, MD", "affiliation": "University of Michigan", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "University of Michigan", "city": "Ann Arbor", "state": "Michigan", "zip": "48109", "country": "United States", "geoPoint": {"lat": 42.27756, "lon": -83.74088}}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "Pre-assignment weight determined and pulmonary function testing prior to enrollment in observational study\n\nOne time point study when mediators were mesaured.", "recruitmentDetails": "OA Obese Asthma BMI \\>30\n\nNANO Non asthma non obese\n\nANO Asthma non obese\n\nNAO Non asthma obese BMI \\>30\n\nStarted July 2010 completed May 2013", "groups": [{"id": "FG000", "title": "Obese Asthma", "description": "Obese Asthma (OA)\n\nBMI \\> 30 Obese\n\nAsthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use."}, {"id": "FG001", "title": "Non Asthma, Non-obese", "description": "BMI 20-25 Non obese"}, {"id": "FG002", "title": "Asthma, Non-obese", "description": "BMI 20-25 Non obese"}, {"id": "FG003", "title": "Non Asthma, Obese", "description": "BMI .30"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "comment": "Aimed to recruit 160 from July 2010 to May 2013. Each subject studied on one time point only", "numSubjects": "30"}, {"groupId": "FG001", "numSubjects": "30"}, {"groupId": "FG002", "numSubjects": "29"}, {"groupId": "FG003", "numSubjects": "28"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "comment": "Study completed at 117 subjects.", "numSubjects": "30"}, {"groupId": "FG001", "numSubjects": "30"}, {"groupId": "FG002", "numSubjects": "29"}, {"groupId": "FG003", "numSubjects": "28"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Obese Asthma (OA)", "description": "BMI \\> 30 Obese\n\nAsthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use."}, {"id": "BG001", "title": "Non Asthma Non-obese (NANO)", "description": "BMI 20-25 Non obese"}, {"id": "BG002", "title": "Asthma Non Obese (ANO)", "description": "BMI 20-25 Non obese\n\nAsthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use."}, {"id": "BG003", "title": "Non Asthma Obese (NAO)", "description": "BMI \\> 30 Obese"}, {"id": "BG004", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "30"}, {"groupId": "BG001", "value": "30"}, {"groupId": "BG002", "value": "29"}, {"groupId": "BG003", "value": "28"}, {"groupId": "BG004", "value": "117"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "44.0", "spread": "10.3"}, {"groupId": "BG001", "value": "31.5", "spread": "11.6"}, {"groupId": "BG002", "value": "29.9", "spread": "9.8"}, {"groupId": "BG003", "value": "42.7", "spread": "13.6"}, {"groupId": "BG004", "value": "37.0", "spread": "13.6"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "21"}, {"groupId": "BG001", "value": "15"}, {"groupId": "BG002", "value": "20"}, {"groupId": "BG003", "value": "21"}, {"groupId": "BG004", "value": "77"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "9"}, {"groupId": "BG001", "value": "15"}, {"groupId": "BG002", "value": "9"}, {"groupId": "BG003", "value": "7"}, {"groupId": "BG004", "value": "40"}]}]}]}, {"title": "BMI", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "kg/m^2", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "38.9", "spread": "6.1"}, {"groupId": "BG001", "value": "22.9", "spread": "1.7"}, {"groupId": "BG002", "value": "22.8", "spread": "1.7"}, {"groupId": "BG003", "value": "37.7", "spread": "5.4"}, {"groupId": "BG004", "value": "30.8", "spread": "9.2"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Plasma Leptin", "description": "Measurement of plasma leptin in obese and non obese asthmatics and non-asthmatic subjects from a single blood draw.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ng/ml", "timeFrame": "Observational: one time point from a blood draw after more than 6 hours fasting", "groups": [{"id": "OG000", "title": "Obese Asthma (OA)", "description": "BMI \\> 30 Obese\n\nAsthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use."}, {"id": "OG001", "title": "Non Asthma Non-obese (NANO)", "description": "BMI 20-25 Non obese"}, {"id": "OG002", "title": "Asthma Non Obese (ANO)", "description": "BMI 20-25 Non obese\n\nAsthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use."}, {"id": "OG003", "title": "Non Asthma Obese (NAO)", "description": "BMI \\> 30 Obese"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "30"}, {"groupId": "OG002", "value": "29"}, {"groupId": "OG003", "value": "28"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "55.4", "spread": "26.9"}, {"groupId": "OG001", "value": "8.9", "spread": "8.8"}, {"groupId": "OG002", "value": "24.2", "spread": "12.9"}, {"groupId": "OG003", "value": "46.5", "spread": "24.2"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001", "OG002", "OG003"], "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<0.0001", "pValueComment": "Hypothesis that leptin levels in OA is not different from the other 3 groups.", "statisticalMethod": "ANOVA"}]}, {"type": "PRIMARY", "title": "Exhaled Nitric Oxide (FeNO)", "description": "Exhaled breath nitic oxide ppb (averaged values from 2 exhalations per participant)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "parts per billion (ppb)", "timeFrame": "Observational: Two exhalations within 1 minute", "groups": [{"id": "OG000", "title": "Obese Asthma (OA)", "description": "BMI \\> 30 Obese\n\nAsthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use."}, {"id": "OG001", "title": "Non Asthma Non-obese (NANO)", "description": "BMI 20-25 Non obese"}, {"id": "OG002", "title": "Asthma Non Obese (ANO)", "description": "BMI 20-25 Non obese\n\nAsthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use."}, {"id": "OG003", "title": "Non Asthma Obese (NAO)", "description": "BMI \\> 30 Obese"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "30"}, {"groupId": "OG002", "value": "29"}, {"groupId": "OG003", "value": "28"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "17.8", "spread": "9.3"}, {"groupId": "OG001", "value": "20.7", "spread": "14.0"}, {"groupId": "OG002", "value": "29.5", "spread": "22.4"}, {"groupId": "OG003", "value": "19.9", "spread": "10.4"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001", "OG002", "OG003"], "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.002", "statisticalMethod": "ANOVA"}]}, {"type": "PRIMARY", "title": "Urine Cysteinyl Leukotriene Per Creatinine", "description": "Urine inflammatory mediators measured from a single urine sample", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "pg/mg creatinine", "timeFrame": "sample taken over 5 minutes or less", "groups": [{"id": "OG000", "title": "Obese Asthma (OA)", "description": "BMI \\> 30 Obese\n\nAsthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use."}, {"id": "OG001", "title": "Non Asthma Non-obese (NANO)", "description": "BMI 20-25 Non obese"}, {"id": "OG002", "title": "Asthma Non Obese (ANO)", "description": "BMI 20-25 Non obese\n\nAsthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use."}, {"id": "OG003", "title": "Non Asthma Obese (NAO)", "description": "BMI \\> 30 Obese"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "30"}, {"groupId": "OG002", "value": "29"}, {"groupId": "OG003", "value": "28"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "7.21", "spread": "3.2"}, {"groupId": "OG001", "value": "6.35", "spread": "3.3"}, {"groupId": "OG002", "value": "6.31", "spread": "2.65"}, {"groupId": "OG003", "value": "6.67", "spread": "3.3"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001", "OG002", "OG003"], "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.725", "statisticalMethod": "ANOVA"}]}, {"type": "PRIMARY", "title": "Ratio U Cys-LT/FeNO", "description": "Responsiveness to leukotriene modifier medication by measuring the urine cysteinyl leukotriene/exhaled nitric oxide ratio", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ratio", "timeFrame": "sample taken over 5 minutes or less", "groups": [{"id": "OG000", "title": "Obese Asthma (OA)", "description": "BMI \\> 30 Obese\n\nAsthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use."}, {"id": "OG001", "title": "Non Asthma Non-obese (NANO)", "description": "BMI 20-25 Non obese"}, {"id": "OG002", "title": "Asthma Non Obese (ANO)", "description": "BMI 20-25 Non obese\n\nAsthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use."}, {"id": "OG003", "title": "Non Asthma Obese (NAO)", "description": "BMI \\> 30 Obese"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "30"}, {"groupId": "OG002", "value": "29"}, {"groupId": "OG003", "value": "28"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.5", "spread": "0.4"}, {"groupId": "OG001", "value": "0.42", "spread": "0.3"}, {"groupId": "OG002", "value": "0.3", "spread": "0.21"}, {"groupId": "OG003", "value": "0.44", "spread": "0.21"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001", "OG002", "OG003"], "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.16", "statisticalMethod": "ANOVA"}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "eventGroups": [{"id": "EG000", "title": "Obese Asthma (OA)", "description": "BMI \\> 30 Obese\n\nAsthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use.", "seriousNumAffected": 0, "seriousNumAtRisk": 30, "otherNumAffected": 0, "otherNumAtRisk": 30}, {"id": "EG001", "title": "Non Asthma Non-obese (NANO)", "description": "BMI 20-25 Non obese", "seriousNumAffected": 0, "seriousNumAtRisk": 30, "otherNumAffected": 0, "otherNumAtRisk": 30}, {"id": "EG002", "title": "Asthma Non Obese (ANO)", "description": "BMI 20-25 Non obese\n\nAsthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use.", "seriousNumAffected": 0, "seriousNumAtRisk": 29, "otherNumAffected": 0, "otherNumAtRisk": 29}, {"id": "EG003", "title": "Non Asthma Obese (NAO)", "description": "BMI \\> 30 Obese", "seriousNumAffected": 0, "seriousNumAtRisk": 28, "otherNumAffected": 0, "otherNumAtRisk": 28}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": true}, "pointOfContact": {"title": "Michael Coffey M.D.", "organization": "University of Michigan", "email": "coffeym@umich.edu", "phone": "734-936-6267"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}, {"id": "D000009765", "term": "Obesity"}], "ancestors": [{"id": "D000050177", "term": "Overweight"}, {"id": "D000044343", "term": "Overnutrition"}, {"id": "D000009748", "term": "Nutrition Disorders"}, {"id": "D000001835", "term": "Body Weight"}, {"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M12701", "name": "Obesity", "asFound": "Obesity", "relevance": "HIGH"}, {"id": "M26186", "name": "Overweight", "relevance": "LOW"}, {"id": "M25307", "name": "Overnutrition", "relevance": "LOW"}, {"id": "M12684", "name": "Nutrition Disorders", "relevance": "LOW"}, {"id": "M5114", "name": "Body Weight", "relevance": "LOW"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC18", "name": "Nutritional and Metabolic Diseases"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}]}}, "hasResults": true}